Latest Leverage News

Medallion Metals Limited advances acquisition talks with IGO Limited for the Cosmic Boy Process Plant while reporting strong drilling results and a promising scoping study for its Ravensthorpe Gold Project.

dorsaVi reported a modest 1.9% rise in sales revenue to $330k in Q2 FY25, launched its AI-powered Video AI movement analysis platform, and initiated a blockchain integration partnership to enhance data security.

Cygnus Metals has completed its merger with Doré Copper, securing a strong cash position and delivering promising early drilling results at its Chibougamau Project in Quebec. The company is poised for an aggressive exploration and resource growth campaign in 2025.

IODM Limited reported a decline in cash reserves to $461,000 for the December quarter, while projecting revenue growth through new university client onboarding in the UK and North America.

InFocus Group Holdings has marked a pivotal quarter with a major $2.5 million contract in digital gaming and a corporate rebrand signaling its shift to enterprise software and analytics. The imminent Prodigy9 acquisition and capital raise position the company for accelerated growth.

Sun Silver Limited reports a highly successful inaugural drilling program at its Maverick Springs Silver-Gold Project in Nevada, revealing multiple thick, high-grade mineral intercepts and a 34% increase in land holdings.

Mastermyne Group Limited reported a 14% rise in EBITDA to $4.1 million for FY25 Q2, even as revenue fell 10% due to operational disruptions at Anglo American’s Grosvenor mine. The company secured key contract extensions and maintained a strong cash position, positioning itself for growth amid sector uncertainties.

Patriot Lithium Limited has made significant strides in acquiring and exploring copper projects in Zambia while navigating complex negotiations for its key Gorman Lithium Project in Canada.

Pancontinental Energy reports encouraging technical progress on its PEL 87 project with improved reservoir confidence and ongoing drilling success in Namibia’s Orange Basin, underpinning a solid cash position.

Prophecy International has inked a three-year global reseller agreement with US SIEM leader Securonix, aiming to generate over $1 million in new annual recurring revenue within the first year.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for Autosomal Dominant Optic Atrophy, marking a pivotal step in developing a treatment for this currently untreatable blinding disease.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.